CAS: 141206-42-0 - N-Butyl-1-deoxygalactonojirimycin
N-(n-Butyl)deoxygalactonojirimycin
CAS:141206-42-0
Formula:
C10H21NO4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
219.2780
Ref: IN-DA009DYX
| 1mg | 182.00 € | ||
| 5mg | 490.00 € |
Estimated delivery in United States, on Thursday 2 Jan 2025
Ref: 4Z-M-249003
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
(2R,3S,4R,5S)-1-(But-1-yl)-2-(hydroxymethyl)piperidine-3,4,5-triol
CAS:141206-42-0
Formula:
C10H21NO4
Purity:
98% (Typical Value in Batch COA)
Color and Shape:
off-white solid
Molecular weight:
219.28g/mol
Ref: 54-OR9050T
| 1mg | 277.00 € | ||
| 5mg | 456.00 € | ||
| 25mg | 1,367.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
N-(n-Butyl)deoxygalactonojirimycin
Controlled ProductCAS:141206-42-0
Applications N-(n-Butyl)deoxygalactonojirimycin is an extremely potent and selective a-D-galactosidase inhibitor. A selective inhibitior of GlcCer …
Formula:
C10H21NO4
Color and Shape:
White Solid
Molecular weight:
219.28
Ref: TR-B690500
| 1mg | 125.00 € | ||
| 5mg | 264.00 € | ||
| 25mg | 1,142.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
N-Butyldeoxygalactonojirimycin
CAS:141206-42-0
Competitive inhibitor of glucosylceramidase (GlcCer), which catalyses the first step in glycosphingolipid (GSL) synthesis. This …
Formula:
C10H21NO4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
219.28 g/mol
Ref: 3D-MB04497
| 1mg | 217.00 € | ||
| 2mg | 325.00 € | ||
| 5mg | 542.00 € | ||
| 10mg | 861.00 € | ||
| 25mg | 1,783.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Lucerastat
CAS:141206-42-0
Lucerastat is a very effective and selective α-gal A (α-D-galactosidase) inhibitor for the treatment of …
Formula:
C10H21NO4
Color and Shape:
Solid
Molecular weight:
219.28
Ref: TM-T32923
| 25mg | 725.00 € | ||
| 50mg | 941.00 € | ||
| 100mg | 1,664.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
